文献速递免疫规划

回到未来:2011/12年接种三价流感疫苗前使用M-001免疫增强了针对2014/15流行株的保护性免疫应答

Back to the future: Immunization with M-001 prior to trivalent influenza vaccine in 2011/12 enhanced protective immune responses against 2014/15 epidemic strain.
PubMed 文献 · Vaccine · 2017-01-05

该研究基于2011/12年老年人研究,发现三价流感疫苗前3周接种M-001可增强针对当时流行株的血凝抑制抗体血清转化;2011年血清显示M-001 priming组对2014/15流行株A/Switzerland/9715293/2013(H3N2-like)的HAI抗体显著更多,血清保护和血清转化改善。

要点

  • M-001提前3周接种可增强三价流感疫苗的HAI抗体血清转化。
  • 2011年血清中M-001组对2014/15 H3N2流行株HAI抗体显著更多。
  • M-001可提供针对未来流行株的广谱增强免疫。

核心结论

  • M-001可提供广谱增强免疫,甚至延伸至未来年份将流行的流感株。
  • M-001刺激T细胞活化且缺乏HA超变表位,提示其广谱HAI应答由广泛T细胞 priming 所致。

研究设计与样本

  • 基于2011/12年老年人研究的后续血清分析,该研究先前报告了M-001在三价流感疫苗前3周接种。

主要发现

  • 2011年血清中,M-001 priming组对A/Switzerland/9715293/2013(H3N2-like)的HAI抗体显著更多,血清保护和血清转化改善。
  • 该H3N2样株引起2014/15流感流行,且2011/12年未知其流行。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

We previously reported a 2011/12 study in elderly showing that immunization with the universal influenza vaccine candidate, M-001, three weeks before administering trivalent influenza vaccine (TIV) enhanced seroconversion of Hemagglutination Inhibition (HAI) antibodies against known influenza vaccine strains circulating at that time. We now report that those subjects primed with M-001 prior to TIV in 2011 also showed, in their 2011 sera, significantly more HAI antibodies with improved seroprotection and seroconversion against strain A/Switzerland/9715293/2013(H3N2-like) that caused the 2014/15 influenza epidemic and that wasn't known to circulate in 2011/12. These data indicate that M-001 can provide broadened enhanced immunity extending even to influenza strains destined to circulate in future years. The fact that M-001 stimulates T cell activation and is devoid of HA hypervariable epitopes indicates that such broadened HAI responses effected by M-001 priming is due to extensive T cell priming.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Lowell GH, Ziv S, Bruzil S, et al. Back to the future: Immunization with M-001 prior to trivalent influenza vaccine in 2011/12 enhanced protective immune responses against 2014/15 epidemic strain. Vaccine. 2017. PMID: 28065476. doi:10.1016/j.vaccine.2016.12.063

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。